During a recent Breakthrough T1D Facebook Live event, a panel from Medtronic Diabetes discussed Medtronic’s efforts to support the T1D community during the coronavirus disease (COVID-19) pandemic.
Members of the panel included Executive Vice President and President of Medtronic Diabetes Sean Salmon, as well as other leaders from Medtronic. Breakthrough T1D Vice President of Corporate Development Joe Watterson and Senior Director of Marketing for Medtronic Diabetes Charles Cush delivered introductory remarks.
The panelists addressed a variety of topics, including:
-
Medtronic’s COVID-19 response, including how they have been listening to and working with the T1D community and health care professionals (presented by Salmon)
-
Medtronic Assurance Program (presented by Vice President of Health Economics, Reimbursement & Government Affairs, Medtronic Diabetes, Jeff Farkas)
-
Optimizing Remote Telemedicine Appointments (presented by Chief Medical Officer, Medtronic Diabetes, Robert Vigersky, M.D.)
-
Supporting People Living with T1D in a Virtual World (presented by National Clinical Director, Medtronic Diabetes, Kim Larson)
Watch the full, recorded livestream:
